-
101دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
102دورية أكاديمية
المؤلفون: Olivieri, A, Corvatta, L, Montanari, M, Brunori, M, Offidani, M, Ferretti, GF, Centanni, M, Leoni, P
المصدر: Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 21(10):1049-1053
-
103
المؤلفون: Sharmilan Thanandrarajan, Giovanni Insuasti-Beltran, Antje Hoering, Shayu Deshpande, Faith E. Davies, Brian A Walker, Sandra Susanibar, Purvi Patel, Martin Moorhead, Monica Grazziutti, Shmuel Yaccoby, Ginell R. Post, Muthukumar Radhakrishnan, Frits van Rhee, Shadiqul Hoque, Sarah K. Johnson, Leo Rasche, Niels Weinhold, Gareth J. Morgan, Meera Mohan, Bart Barlogie, Pankaj Mathur, Carolina Schinke, Maurizio Zangari, Daisy Alapat, Thomas D. Willis, Jorge Jo Kamimoto, Gabor Molnar, Victoria Carlton, Joshua Epstein, Hongwei Wang
المصدر: Haematologica. 102:e313-e316
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Neoplasm, Residual, Time Factors, Risk Assessment, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Humans, Medicine, Online Only Articles, Multiple myeloma, Risk status, business.industry, Complete remission, High dose melphalan, Hematology, Prognosis, medicine.disease, Novel agents, 030220 oncology & carcinogenesis, Immunology, Stem cell, Multiple Myeloma, business, 030215 immunology
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07cb71517158c03de8a3e08ac1a545d9
https://doi.org/10.3324/haematol.2017.165217 -
104
المؤلفون: Zeynep Arzu Yegin, Fikret Izzettin, Mesut Sancar, Eda Aypar, Gülsan Türköz-Sucak, Şahika Zeynep Akı
المساهمون: İZZETTİN, FIKRET VEHBI
المصدر: Journal of Oncology Pharmacy Practice. 24:281-289
مصطلحات موضوعية: Adult, Male, Oncology, Melphalan, medicine.medical_specialty, Transplantation Conditioning, Standard of care, medicine.medical_treatment, Antineoplastic Agents, Hematopoietic stem cell transplantation, Transplantation, Autologous, Conditioning regimen, Bortezomib, 03 medical and health sciences, 0302 clinical medicine, Autologous stem-cell transplantation, immune system diseases, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Pharmacology (medical), cardiovascular diseases, Antineoplastic Agents, Alkylating, neoplasms, Multiple myeloma, Aged, Retrospective Studies, Dose-Response Relationship, Drug, business.industry, Hematopoietic Stem Cell Transplantation, High dose melphalan, Middle Aged, medicine.disease, 030220 oncology & carcinogenesis, Female, Multiple Myeloma, business, 030215 immunology, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54de039caeffbc5eccdd0ce021950beb
https://doi.org/10.1177/1078155217697486 -
105دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
106دورية أكاديمية
المؤلفون: Weaver, CH, Greco, FA, Hainsworth, JD, Zhen, B, Baldwin, P, Wittlin, F, Lewis, M, West, WH, Schwartzberg, L, Buckner, CD
المصدر: Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 20(10):847-853
-
107دورية أكاديمية
المؤلفون: Jagannath, S, Vesole, DH, Zhang, M, Desikan, KR, Copeland, N, Jagannath, M, Bracy, D, Jones, R, Crowley, J, Tricot, G, Barlogie, B
المصدر: Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 20(6):445-450
-
108High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers
المؤلفون: Vaishali Sanchorawala, Pooja Phull, Shayna Sarosiek, Karen Quillen, Dina Brauneis, J. Mark Sloan, Paul S White
المصدر: Bone Marrow Transplantation. 53:1593-1595
مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Cardiac biomarkers, 03 medical and health sciences, 0302 clinical medicine, Text mining, Internal medicine, AL amyloidosis, Humans, Medicine, Melphalan, Aged, Transplantation, business.industry, High dose melphalan, Amyloidosis, Hematology, Middle Aged, medicine.disease, 030220 oncology & carcinogenesis, Female, Stem cell, business, Biomarkers, Stem Cell Transplantation, 030215 immunology
-
109
المؤلفون: Shayna Sarosiek, Vina P. Nguyen, Michelle Kaku, John Mark Sloan, Vaishali Sanchorawala, Dina Brauneis, Anthony C Shelton, Karen Quillen
المصدر: Bone Marrow Transplantation. 53:371-373
مصطلحات موضوعية: Neuralgic amyotrophy, Transplantation, Pathology, medicine.medical_specialty, business.industry, High dose melphalan, Hematology, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, AL amyloidosis, medicine, Peripheral Blood Stem Cell Transplantation, business, 030217 neurology & neurosurgery
-
110
المؤلفون: Sandra Croockewit, Pieter Sonneveld, Kazem Nasserinejad, Paula F. Ypma, Sonja Zweegman, Esther G. M. de Waal, Annemieke Broijl, Monique C. Minnema, Harry R. Koene, Ka Lung Wu, Marie José Kersten, Gerard M. J. Bos, Stefan Schönland, M Ron Schaafsma, Bouke P. C. Hazenberg, Lidwien Tick, Ute Hegenbart, Philip Vlummens, Nicolaus Kröger
المساهمون: Interne Geneeskunde, MUMC+: MA Hematologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Hematology, Translational Immunology Groningen (TRIGR)
المصدر: Haematologica
Haematologica-the Hematology Journal, 104(11), 2274-2282. Ferrata Storti Foundation
Minnema, M C, Nasserinejad, K, Hazenberg, B, Hegenbart, U, Vlummens, P, Ypma, P F, Kröger, N, Wu, K L, Kersten, M J, Schaafsma, M R, Croockewit, S, de Waal, E, Zweegman, S, Tick, L, Broijl, A, Koene, H, Bos, G, Sonneveld, P & Schönland, S 2019, ' Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: Results of the multicenter HOVON 104 trial ', Haematologica, vol. 104, no. 11, pp. 2274-2282 . https://doi.org/10.3324/haematol.2018.213900
Haematologica, 104(11), 2274-2282. Ferrata Storti Foundation
Haematologica, 104(11), 2274. Ferrata Storti Foundation
Haematologica, 104(11), 2274-2282. FERRATA STORTI FOUNDATION
Haematologica, 104, 11, pp. 2274-2282
Haematologica, 104, 2274-2282
HAEMATOLOGICAمصطلحات موضوعية: Melphalan, Male, BLOOD, Phases of clinical research, PROGRESSION, Gastroenterology, THERAPY, Severity of Illness Index, Plasma Cell Disorders, Bortezomib, 0302 clinical medicine, Autologous stem-cell transplantation, immune system diseases, hemic and lymphatic diseases, CYCLOPHOSPHAMIDE, Medicine and Health Sciences, Clinical endpoint, Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, Combined Modality Therapy, Hematologic Response, DEXAMETHASONE, surgical procedures, operative, Treatment Outcome, HIGH-DOSE MELPHALAN, Disease Progression, Female, CARDIAC BIOMARKERS, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug, HEMATOLOGIC RESPONSE, medicine.medical_specialty, SYSTEMIC AL AMYLOIDOSIS, Transplantation, Autologous, Article, Immunophenotyping, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Internal medicine, medicine, AL amyloidosis, Journal Article, Humans, Aged, business.industry, STAGING SYSTEM, medicine.disease, Transplantation, business, Biomarkers, 030215 immunology
وصف الملف: image/pdf; application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24b31ee17d8ab61f75226a7615039d08
https://pubmed.ncbi.nlm.nih.gov/30923094